A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Anaesthesia
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 26 Sep 2017 Planned number of patients changed from 72 to 120.
- 10 Feb 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
- 09 Jan 2017 New trial record